Standards for Medication-Assisted Treatment for Opioid Use Disorders, Needs Assessment for Medication-Assisted Treatment for Opioid Use Disorders, Clinical and Operational Standards for Medication-Assisted Treatment for Opioid Use Disorders
DEPARTMENT OF CHILDREN AND FAMILIES
RULE NOS.:RULE TITLES:
65D-30.014Standards for Medication-Assisted Treatment for Opioid Use Disorders
65D-30.0141Needs Assessment for Medication-Assisted Treatment for Opioid Use Disorders
65D-30.0142Clinical and Operational Standards for Medication-Assisted Treatment for Opioid Use Disorders
NOTICE OF CHANGE
Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 46 No. 21, January 31, 2020 issue of the Florida Administrative Register.
65D-30.014 Standards for Medication-Assisted Treatment for Opioid Use Disorders.
(1) No change.
(2) Federal Authority. The federal authority is the Center for Substance Abuse Treatment.
This rule shall remain in effect for a period of sunsets five years after its from the effective date and shall be reviewed by the Department for its continued necessity at least 90 days before its expiration. of the rule.
Rulemaking Authority 397.321(5) FS. Law Implemented 397.311(26), 397.321, 397.410, 397.427, 427 FS. History–New 5-25-00, Amended 4-3-03, 6-25-19. Amended____
65D-30.0141 Needs Assessment for Medication-Assisted Treatment for Opioid Use Disorders.
(1) No change.
(2) Awarded applicants must receive at least a probationary license within two (2) years of receipt of an award letter connected to their “Methadone Medication-Assisted Treatment (MAT) Application to Proceed to Licensure Application” form, CF-MH 4041. If an applicant fails to obtain a probationary license within the specified time, the Department shall rescind the award. See rule 65D-30.0036, F.A.C. for licensure application requirements. Applicants may submit a request to the State Authority and Substance Abuse and Mental Health Program Office for an exception if unable to meet timeframes due to a natural disaster that causes physical damage to the applicant’s building(s). Proof of natural disaster and impact on physical property must accompany the request. Upon receipt of the request for exception and accompanying proof, a one-time extension shall be granted for six (6) months. Providers who are delayed for a reason other than a natural disaster may petition the Department for a rule waiver pursuant to section 120.542, F.S.
This rule shall remain in effect for a period of sunsets five years after its from the effective date and shall be reviewed by the Department for its continued necessity at least 90 days before its expiration. of the rule.
Rulemaking Authority 397.321(5) FS. Law Implemented 397.311(26), 397.321, 397.407, 397.410, 397.427, 427 FS. History–New
65D-30.0142 Clinical and Operational Standards for Medication-Assisted Treatment for Opioid Use Disorders.
(1) No change.
(2) Maintenance Treatment Standards.
(a) through (f) No change.
(g) Methadone Take-home Privileges.
1. Take-home doses of methadone are permitted only for individuals participating in a methadone medication-assisted treatment program. Requests for take-home doses greater than the amount allowed, as stipulated in paragraph (2)(h) (5)(h) of this rule, must be entered into the Substance Abuse and Mental Health Services Administration/Center for Substance Abuse Treatment (SAMHSA/CSAT) Opioid Treatment Program Extranet for federal and state approval. The following must be indicated on the exception request:
a. through f. No change.
2. through 5. No change.
(h) Take-home Phases. To be considered for take-home privileges, all individuals shall be in compliance with criteria as stated in 42 CFR 8.12(i)(2).
1. through 2. No change.
3. Methadone Medical Maintenance. Providers may place an individual on methadone medical maintenance in cases where it can be demonstrated that the potential benefits of medical maintenance to the individual exceed the potential risks, in the professional judgment of the physician. Only a physician may authorize placement of an individual on medical maintenance. The physician shall provide justification in the clinical record regarding the decision to place an individual on medical maintenance.
The following conditions shall apply to medical maintenance.
a. through d. No change.
e. All criteria for take-homes as listed under paragraph (2)(g) (5)(g) shall continue to be met.
(i) through (r) No change.
(3) through (4) No change.
(5) Other Medications.
(a) through (b) No change.
(c) Providers shall adhere to the prevailing federal and state requirements regarding the use of opioid treatment medications in the maintenance treatment of individuals who are or become pregnant during the course of treatment.
This rule shall remain in effect for a period of sunsets five years after its from the effective date and shall be reviewed by the Department for its continued necessity at least 90 days before its expiration. of the rule.
Rulemaking Authority 397.321(5) FS. Law Implemented 397.311(26), 397.321, 397.410, 397.427, 427 FS. History–New
